Pharmaceuticals
Healthcare
Venus Remedies looking to raise $20M through QIP
Chandigarh-based listed pharma company Venus Remedies Limited, is looking to raise funds for marketing and other purposes, a top executive ......
Healthcare
CCI says Sun-Ranbaxy deal may hit competition
Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today said it has prima ......
Healthcare
Sun-Ranbaxy deal: CCI raises concerns about molecules market
The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, today said the major issue is ......
Healthcare
CCI expands probe into Sun-Ranbaxy deal
Widening its scrutiny of the multi-billion dollar Sun Pharma-Ranbaxy deal, fair trade watchdog CCI has asked the two pharma majors ......
Healthcare
Biocon subsidiary Syngene International looking to raise over $50M
Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development ......
Healthcare
UK-based private drug maker NRIM to increase stake in nutraceuticals maker Kinedex
UK-based pharma player NRIM is raising its holding in Kinedex Healthcare Pvt Ltd, a Mumbai-based manufacturer and marketer of nutraceuticals ......
Healthcare
Sabre Partners leads $8M Series B investment in Vyome Biosciences
Vyome Biosciences Pvt Ltd, which is a biopharmaceutical company focused on developing dermatology products, has closed a Series B financing round ......
Healthcare
Sequoia Capital bets on startup drug maker Koye Pharma
Venture capital firm Sequoia Capital is investing additional amount in one-year-old primary specialty care drug maker Koye Pharmaceuticals Pvt Ltd, ......
Healthcare
Sanofi partners Bain Capital-backed Emcure for oncology drugs portfolio in India
Global pharmaceutical major Sanofi has entered into a marketing and distribution agreement with Emcure Pharmaceuticals (Emcure) for its oncology portfolio ......
Healthcare
Kitara Capital raising stake in Vivimed Labs
Mumbai-based private equity firm Kitara Capital, which is focused on investing in public market firms, is raising its holding in ......